The twiist AID system is designed to directly measure the volume and flow of insulin with every micro-dose, and address an individual’s dosing needs. Using the FDA-cleared Tidepool Loop technology, ...
NEW ORLEANS, June 08, 2026 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, today announced results from a multi-center pivotal trial evaluating the safety and efficacy of the investigational twiist™ ...
MANCHESTER, N.H., March 18, 2024 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies, today announced its partner, DEKA Research & Development ...
A new partnership had led to the development of the first-ever automated insulin delivery (AID) system that incorporates a 1-year glucose sensor. The twiist AID is approved for people aged 6 years or ...
MANCHESTER, N.H., May 22, 2025 (GLOBE NEWSWIRE) -- Sequel Med Tech, LLC, a company developing state-of-the-art insulin delivery technologies today announced a commercial development agreement for ...
Senseonics and newcomer pump developer Sequel Med Tech have a plan to connect their diabetes technologies, with the goal of delivering what they describe as the first automated insulin delivery system ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results